Authors:
Ibanez, L
Ballarin, E
Vidal, X
Laporte, JR
Citation: L. Ibanez et al., Agranulocytosis associated with calcium dobesilate - Clinical course and risk estimation with the case-control and the case-population approaches, EUR J CL PH, 56(9-10), 2000, pp. 763-767
Authors:
Aguado, A
Barcelo, E
Bendahann, G
Cucurull, E
Diogene, E
Fernandez, E
Garcia, N
Guell, S
Laporte, JR
Llop, R
Casadevall, J
Sabate, N
Rodriguez, D
Valles, JA
Citation: A. Aguado et al., Selection of antihypertensive drug treatment in primary health care, MED CLIN, 114(10), 2000, pp. 374-377
Authors:
Bonet, S
Agusti, A
Arnau, JM
Vidal, X
Diogene, E
Galve, E
Laporte, JR
Citation: S. Bonet et al., beta-adrenergic blocking agents in heart failure - Benefits of vasodilating and nonvasodilating agents according to patients' characteristics: A meta-analyis of clinical trials, ARCH IN MED, 160(5), 2000, pp. 621-627
Authors:
Bonet, S
Agusti, A
Arnau, JM
Vidal, X
Diogene, E
Galve, E
Laporte, JR
Citation: S. Bonet et al., beta-blockers in congestive heart failure: Is there a difference between classes? In reply, ARCH IN MED, 160(19), 2000, pp. 3005-3006
Authors:
Vallano, A
Aguilera, C
Arnau, JM
Banos, JE
Laporte, JR
Citation: A. Vallano et al., Management of postoperative pain in abdominal surgery in Spain. A multicentre drug utilization study, BR J CL PH, 47(6), 1999, pp. 667-673
Authors:
Vilardell, M
Sabat, D
Arnaiz, JA
Bleda, MJ
Castel, JM
Laporte, JR
Vallve, C
Citation: M. Vilardell et al., Topical heparin for the treatment of acute superficial phlebitis secondaryto indwelling intravenous catheter - A double-blind, randomized, placebo-controlled trial, EUR J CL PH, 54(12), 1999, pp. 917-921